Quick Investor Guide To Pharmaceutical ETFs

healthcare-etfsWith the year coming to an end, the worst of the patent cliff faced by the pharmaceutical sector in recent times is over. Although genericization will continue, the major patent expiries are over and done with.
NYSE:IHE December 26, 2013 2:09pm

ETFs Which Look To Benefit From The Affordable Care Act

ObamaCareThe Affordable Care Act—often known as Obamacare—has faced an incredible amount of scrutiny over the past few years. First, the law was fought in Congress, then in the court system,
NYSE:PJP December 22, 2013 9:53pm

3 Pharmaceutical ETFs Leading The Healthcare Sector

healthcare1The pharmaceutical industry has been performing remarkably well this year after emerging relatively unscathed from one of the biggest patent cliffs in recent times.
NYSE:IHE November 26, 2013 12:11am

How To Play The Bullish Trend In Healthcare With ETFs

healthcare-etfsWhile there have been a series of volatility-inducing events in the U.S. starting from the Fed’s ‘Taper Talk’ and then the tussle between the Republicans and the Democrats, investors have still remained relatively bullish and have put capital
NYSE:BBH November 1, 2013 1:57pm

Why Investors Should Consider Pharmaceutical ETFs

healthcare-etfsThe healthcare space, no doubt, is one of the leading sectors this year courtesy of the incredible performances by major drug companies in both pharmaceutical and biotechnology industries. While the biotech sector includes the fastest growing
NYSE:IHE August 26, 2013 12:19pm

Investor Guide To Four Pharmaceutical ETFs

healthcare3The pharmaceutical industry has been showing signs of recovery from one of the biggest patent cliffs in recent times. Although genericization will continue, the major patent expiries are over and done with. Focus in the pharma sector is now shifting
NYSE:IHE August 12, 2013 4:27pm

3 Best (And 3 Worst) ETF Performers Over The Last 3 Years (THD, PJP, SIVR, VXX, KWT, GAZ)

Carolyn Pairitz: This past year has been marked by uncertainty, but nothing compared to recent years, prompting investors to return in droves from safe haven accounts to the U.S. stock market. Investors have their eyes fixed on major indexes and other indicators to judge the
NYSE:GAZ November 23, 2012 11:56am

Balchunas on the Rally in Some Pharmaceutical ETFs (IHE, XPH, PJP)

Bloomberg ETF analyst Eric Balchunas discusses the rally in three exchange-traded funds that focus on the pharmaceutical industry. Bloomberg Radio's
NYSE:IHE October 25, 2012 12:38pm

Three ETFs With Surprisingly Stellar 3-Year Returns (THD, RTL, REZ, PJP)

Daniela Pylypczak: For the most part, many people would agree that  investing can sometimes be a crapshoot. Investors often find themselves playing a game of musical chairs,
NYSE:PJP August 25, 2012 10:45am

What Patent Cliff? Pharmaceutical ETFs Continue To Surge (PJP, XPH, IHE, JNJ, PFE, AMGN, MRK, VVUS)

Eric Dutram: For at least the past few years, investors in the health care segment have been focused in on big pharma and the segment’s fast approaching ‘patent cliff’. During this period, many of the industry’s most popular and best selling drugs
NYSE:IHE July 11, 2012 11:47am

The 5 Best ETFs Over The Past 5 Years (IAU, SLV, FBT, TLT, PJP, SPY)

Eric Dutram: In the last five years, investors have witnessed a variety of market conditions. Stocks were relatively strong in the middle part of 2007 but, as we all know, proceeded to fall apart during the turmoil of 2008 and one of the worst recessions in recent memory.
NYSE:FBT July 2, 2012 2:46pm

New Global Big Pharma ETN Hits The Market (DRGS, IHE, PJP, XPH, PPH)

Michael Johnston: RBS rolled out its fifth ETN this week, debuting a product that offers exposure to the world’s largest pharmaceutical firms. The new Global Big Pharma ETN (NYSE:DRGS) will seek to replicate
NYSE:DRGS October 25, 2011 11:23pm

Bright Spots In The ETF Landscape: Five Funds Holding Their Value In A Wild 2011 (EWM, DFJ, ENZL, VPU, PJP)

Michael Johnston: So far, this year has been tough for markets around the globe. Since the downgrade of U.S. credit quality in August, equity markets have become plagued with rampant volatility, discouraging capital inflows and prompting many investors to pull out of the markets entirely. Just when the
NYSE:DFJ October 21, 2011 4:47pm

The Pharma Four: Similar ETFs, Different Returns (PPH, XPH, IHE, PJP, XLV)

Jared Cummans: Pharmaceutical companies have long been popular investments as they offer relatively inelastic products as well as strong dividend yields that give both growth and value investors something to buy into. As far as the ETF world is concerned, there are four products that allow investors to gain
NYSE:IHE October 17, 2011 3:35pm

Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular

From Our Partners

Explore More from ETFDailyNews.com

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again!

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories